Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Nov 4;26(6):244-247.
doi: 10.1097/NRL.0000000000000341.

Responsiveness of 2 Different Ability Outcome Measures in Guillain-Barré Syndrome

Aleksandar Stojanov  1 , Ivana Basta  2 , Ivana Berisavac  2 , Olivera Stojiljkovic-Tamas  2 , Ivo Bozovic  2 , Mirjana Arsenijevic  2 , Aleksa Palibrk  2 , Stojan Peric  2
Affiliations
Multicenter Study

Responsiveness of 2 Different Ability Outcome Measures in Guillain-Barré Syndrome

Aleksandar Stojanov et al. Neurologist. .

Abstract

Background: The most frequently used ability outcome measure in Guillain-Barré syndrome (GBS) is the GBS disability scale (GDS). Recently developed inflammatory Rasch-built overall disability (I-RODS) scale has been suggested to be used in inflammatory polyneuropathies. In the present study, we wanted to assess the comparative responsiveness of I-RODS and GDS in subjects who were diagnosed with GBS during a follow-up period of 6 months.

Methods: Our prospective, multicentric study included 72 subjects. Patients were tested, using GDS and I-RODS, on day 14, day 28, month 3, and month 6 from the start of the symptoms. We defined improvement as a reduction for 1 or more points on GDS or improvement on I-RODS as defined by Draak (2014).

Results: Between days 14 and 28 there was an improvement in 28% of patients as measured with GDS and only in 10% patients as measured with I-RODS. At month 3 compared with day 14, we noticed an improvement in GDS score in 90% of GBS patients and I-RODS score in 65%. At month 6 improvements were noticed in 94% of patients measured by GDS and 78% according to I-RODS.

Conclusion: Our findings support the use of GDS in an acute phase of GBS. I-RODS have their role mostly during a longer follow-up period when the majority of patients are ambulant and their other abilities besides walking are also of great importance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. van den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–482.
    1. Farmakidis C, Inan S, Milstein M, et al. Headache and pain in Guillain-Barré syndrome. Curr Pain Headache Rep. 2015;19:40.
    1. Drory VE, Bronipolsky T, Bluvshtein V, et al. Occurrence of fatigue over 20 years after recovery from Guillain-Barré syndrome. J Neurol Sci. 2012;316:72–75.
    1. Bersano A, Carpo M, Allaria S, et al. Long term disability and social status change after Guillain-Barré syndrome. J Neurol. 2006;253:214–218.
    1. US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79–99.

Publication types

LinkOut - more resources